Work

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.22.02761

Authors: Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol, Peter J. O'Dwyer, Edith P. Mitchell, Steven R. Alberts, Michael A. Schwartz, Al B. Benson

Institutions: Northwestern University, Fox Chase Cancer Center, Mayo Clinic, Thomas Jefferson University, Mount Sinai Medical Center, Dana-Farber Cancer Institute, University of Pennsylvania

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: ECOG Statistical Office Data Management Grant, G2679961467, G349330619, G3519244048, G3762168461, ECOG Clinical Trials, Eastern Cooperative Oncology Group Operations Office

OpenAlex ID: W4384520842

FWCI: 2.371

Cites:

Cited by: 162

Related to: 10